Pacific Biosciences Of California (PACB) Change in Account Payables (2010 - 2026)

Pacific Biosciences Of California's Change in Account Payables history runs 17 years deep, the most recent figure standing at -$4.3 million for Q1 2026.

• In Q1 2026, Change in Account Payables fell 183.41% year-over-year to -$4.3 million; the TTM figure through Mar 2026 stood at -$315000.0 (up 95.34% YoY), while the FY2025 annual figure was $2.5 million, up 76.65% from the prior year.
• Change in Account Payables was -$4.3 million for Q1 2026 at Pacific Biosciences Of California, down from $1.7 million in the prior quarter.
• In the past five years, Change in Account Payables ranged from a high of $6.6 million in Q1 2024 to a low of -$5.6 million in Q3 2024.
• Historically, Change in Account Payables has averaged $46823.5 across 5 years, with a median of -$486000.0 in 2022.
• The sharpest annual moves came in 2022 and 2023: Change in Account Payables soared 4065.36% in 2022, then plunged 1520.0% in 2023.
• A 5-year view of Change in Account Payables shows it stood at -$486000.0 in 2022, then slumped by 208.64% to -$1.5 million in 2023, then jumped by 341.8% to $3.6 million in 2024, then plunged by 52.55% to $1.7 million in 2025, then sank by 351.13% to -$4.3 million in 2026.
• The last three Change in Account Payables figures came in at -$4.3 million (Q1 2026), $1.7 million (Q4 2025), and $1.3 million (Q3 2025), per Business Quant data.